Literature DB >> 2295044

Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy.

J S Sham1, W I Wei, W H Kwan, C W Chan, W K Kwong, D Choy.   

Abstract

The primary tumor regression pattern of 50 patients with nasopharyngeal carcinoma was reported. The tumor regression was monitored either by indirect nasopharyngeal mirror examination and biopsy or fiberoptic endoscope and biopsy. Fiberoptic endoscope and biopsy was found to be more accurate in noting residual tumor. It is recommended that booster radiation dose to the residual primary tumors be withheld unless positive biopsy samples persist at 10 or more weeks after radiotherapy.

Entities:  

Mesh：

Year:  1990        PMID： 2295044     DOI： 10.1002/1097-0142(19900115)65:2<216::aid-cncr2820650206>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  8 in total

1.  Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.

Authors:  M I Koukourakis; A Giatromanolaki; S Kakolyris; M Froudarakis; V Georgoulias; G Retalis; N Bahlitzanakis
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

2.  Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Chin-Yu Lin; Kai-Ping Chang; Yu-Chun Lin
Journal:  Eur Radiol       Date:  2010-09       Impact factor: 5.315

3.  A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.

Authors:  L Kostakoglu; U Uysal; E Ozyar; F B Demirkazik; M Hayran; L Atahan; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1997-06

4.  MR imaging prediction of local control of nasopharyngeal carcinoma treated with radiation therapy and chemotherapy.

Authors:  Y Wang; H Zhao; Z-Q Zhang; L-L Huang; Y Ye; Y-B Wang; M-J Han
Journal:  Br J Radiol       Date:  2014-05-14       Impact factor: 3.039

5.  A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.

Authors:  Yuxiang He; Qin Zhou; Lin Shen; Yajie Zhao; Mingjun Lei; Rui Wei; Liangfang Shen; Shousong Cao
Journal:  Radiat Oncol       Date:  2015-04-15       Impact factor: 3.481

6.  Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis.

Authors:  Haiqin Peng; Zhanzhan Li; Yujiao Long; Jiahui Li; Zhiyuan Liu; Rongrong Zhou
Journal:  Biosci Rep       Date:  2019-09-20       Impact factor: 3.840

Review 7.  Surveillance tools for detection of recurrent nasopharyngeal carcinoma: An evidence-based review and recommendations.

Authors:  Andrew Thamboo; Kim H Tran; Annette X Ye; Issraa Shoucair; Basel Jabarin; Eitan Prisman; Cathie Garnis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-04-21

8.  Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.

Authors:  Ning Zhang; Shao-Bo Liang; Yan-Ming Deng; Rui-Liang Lu; Hai-Yang Chen; Hai Zhao; Zhi-Qian Lv; Shao-Qiang Liang; Lin Yang; Dong-Sheng Liu; Yong Chen
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.